NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-051-2012-3-CA-02 Neutralizing Antibodies To HIV-1 and Their Use CA National Stage 2858716 Issued
NIAID E-051-2012-3-IN-05 Neutralizing Antibodies To HIV-1 and Their Use IN National Stage 4661/DELNP/2014 Issued
NIAID E-051-2012-3-ZA-07 Neutralizing Antibodies To HIV-1 and Their Use ZA National Stage 2014/04077 Issued
NIAID E-051-2012-3-IT-18 Neutralizing Antibodies To HIV-1 and Their Use IT EP 12855597.6 Issued
NIAID E-051-2012-3-IE-17 Neutralizing Antibodies To HIV-1 and Their Use IE EP 12855597.6 Issued
NIAID E-051-2012-3-EP-04 Neutralizing Antibodies To HIV-1 and Their Use EP National Stage 12855597.6 Issued
NIAID E-051-2012-3-BE-12 Neutralizing Antibodies To HIV-1 and Their Use BE EP 12855597.6 Issued
NIAID E-051-2012-3-DE-14 Neutralizing Antibodies To HIV-1 and Their Use DE EP 12855597.6 Issued
NIAID E-051-2012-3-FR-15 Neutralizing Antibodies To HIV-1 and Their Use FR EP 12855597.6 Issued
NIAID E-051-2012-3-CH-13 Neutralizing Antibodies To HIV-1 and Their Use CH EP 12855597.6 Issued
NIAID E-051-2012-3-GB-16 Neutralizing Antibodies To HIV-1 and Their Use GB EP 12855597.6 Issued
NIAID E-051-2012-3-CN-03 Neutralizing Antibodies To HIV-1 and Their Use CN National Stage 201280069415.3 Issued
NIAID E-051-2012-3-AU-08 Neutralizing Antibodies To HIV-1 and Their Use AU National Stage 2012347453 Issued
NCI E-257-2009-1-HK-08 Use Of IL-15 To Increase Thymic Output and to Treat Lymphopenia HK EP 12112742.2 Issued
NIAID E-051-2012-3-PCT-01 Neutralizing Antibodies To HIV-1 and Their Use PCT PCT PCT/US2012/068827 Expired
NIDDK E-177-2010-0-US-04 Thioether Prodrug Compositions As Anti-HIV And Anti-retroviral Agents US National Stage 13/703,097 Abandoned
NHGRI E-044-2013-0-CH-09 Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lamin A (LMNA) CH EP 12806796.4 Issued
NHGRI E-044-2013-0-GB-12 Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lamin A (LMNA) GB EP 12806796.4 Issued
NHGRI E-044-2013-0-NL-14 Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lamin A (LMNA) NL EP 12806796.4 Issued
NHGRI E-044-2013-0-EP-04 Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lamin A (LMNA) EP National Stage 12806796.4 Issued
NHGRI E-044-2013-0-IE-13 Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lamin A (LMNA) IE EP 12806796.4 Issued
NHGRI E-044-2013-0-DE-10 Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lamin A (LMNA) DE EP 12806796.4 Issued
NHGRI E-044-2013-0-FR-11 Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lamin A (LMNA) FR EP 12806796.4 Issued
NHGRI E-044-2013-0-JP-05 Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lamin JP National Stage 2014-546152 Issued
NHGRI E-044-2013-0-US-02 Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lamin A (LMNA) US ORD 13/708,709 9326992 Issued PDF
NCI E-181-2012-0-PCT-02 TUMOR-SPECIFIC GM-CSF CYTOKINE RESPONSE AS PREDICTOR OF CANCER VACCINE EFFECTIVENESS PCT PCT PCT/US2012/068574 Expired
NHGRI E-044-2013-0-PCT-03 Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lamin A (LMNA) PCT PCT PCT/US2012/068609 Expired
NCI E-181-2012-0-EP-03 TUMOR-SPECIFIC GM-CSF CYTOKINE RESPONSE AS PREDICTOR OF CANCER VACCINE EFFECTIVENESS EP National Stage 12855305.4 Pending
NIDDK E-129-2010-0-US-04 Programmable Self-Assembled Nanostructures Based On Sidechain-Modified PNA For The Multivalent Display Of Ligands US National Stage 13/697,123 Abandoned
NIA E-237-2014-1-US-01 Cerium Oxide Nanoparticles And Associated Methods For Promoting Wound Healing US ORD 13/706,973 Abandoned
NIDDK E-129-2010-0-GB-07 Programmable Self-Assembled Nanostructures Based On Sidechain-Modified PNA For The Multivalent Display Of Ligands GB EP 11721899.0 Issued
NIDDK E-129-2010-0-DE-06 Programmable Self-Assembled Nanostructures Based On Sidechain-Modified PNA For The Multivalent Display Of Ligands DE EP 11721899.0 Issued
NIDDK E-129-2010-0-FR-05 Programmable Self-Assembled Nanostructures Based On Sidechain-Modified PNA For The Multivalent Display Of Ligands FR EP 11721899.0 Issued
NIDDK E-129-2010-0-IE-08 Programmable Self-Assembled Nanostructures Based On Sidechain-Modified PNA For The Multivalent Display Of Ligands IE EP 11721899.0 Issued
NINDS E-043-2012-0-PCT-02 SuBLIME: Automatic Brain Lesion Incidence And Detection Using Multimodality Longitudinal Magnetic Resonance Imaging PCT PCT PCT/US12/067997 Expired
NIAID E-139-2006-0-US-11 Development Of Dengue Virus Vaccine Components US DIV 13/692,557 9090873 Issued PDF
NCI E-058-2015-1-PCT-01 MATERIALS AND METHODS RELATED TO NSAID CHEMOPREVENTION IN COLORECTAL CANCER PCT PCT COMB PCT/US2012/067651 Expired
NIAID E-066-2003-5-US-05 Monoclonal Antibodies That Bind Or Neutralize Dengue Virus US DIV 13/692,521 Abandoned
NCI E-058-2015-1-AU-02 MATERIALS AND METHODS RELATED TO NSAID CHEMOPREVENTION IN COLORECTAL CANCER AU National Stage 2012346899 Abandoned
NIBIB E-005-2012-1-US-01 Multi-Focal Structured Illumination Microscopy Systems and Methods US 61/732,460 Abandoned
NCI E-058-2015-1-CA-05 MATERIALS AND METHODS RELATED TO NSAID CHEMOPREVENTION IN COLORECTAL CANCER CA National Stage 2857712 Abandoned
NIAID E-575-2013-2-PCT-01 VACCINE FOR FALCIPARUM MALARIA PCT PCT COMB PCT/US2012/067404 Expired
NIDA E-249-2012-0-US-01 Therapeutic Polypeptides and Methods of Their Use US 61/732,241 Abandoned
NCATS E-277-2011-1-PCT-01 Modulators Of Lipid Storage PCT PCT COMB PCT/US2012/066394 Expired
NIBIB E-066-2012-0-US-01 Nanoparticles For Delivery Of Ligands US 61/729,159 Abandoned
NCI E-173-2012-2-EP-02 Use of PDL1 Expressing Cells to Convert T Cells Into Regulatory Cells EP National Stage 12851070.8 Issued
NIAID E-323-2005-2-AU-12 Influenza Hemagglutinin And Neuraminidase Variants AU DIV 2012258291 Abandoned
NCI E-173-2012-2-PCT-01 Programmed Death Ligand-1 (PDL1)-transduced K562 Cells Convert Human Th1 Cells Into Regulatory T Cells PCT PCT COMB PCT/US12/066112 Expired
NICHD E-016-2013-0-US-01 Assay To Measure Midkine Or Pleiotrophin Level For Diagnosing A Growth US 61/728,624 Abandoned
NCI E-281-2012-0-US-01 INHIBITORS OF THE T CELL-SPECIFIC ALTERNATIVE P38 ACTIVATION PATHWAY AND METHODS OF USE US 61/728,368 Abandoned